NCT01460914
- Conditions
- Cutaneous T Cell Lymphoma, Graft Versus Host Disease, Graft vs Host Disease, +11 more
- Locations
-
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,025 public trials
2,027 recruiting studies
Immunoproliferative Disorders trial results
NCT02955589
- Conditions
- Adult T-Cell Lymphoma (ATL), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Fukuoka, Japan
- Isehara, Japan
- Kagoshima, Japan
- Miyagi, Japan
NCT00965354
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +15 more
- Locations
-
- Alder Hey Children's Foundation NHS Trust Liverpool, United Kingdom
- Royal Liverpool University Hospital Liverpool, United Kingdom
- Liverpool Women's NHS Foundation Trust Liverpool, United Kingdom
- Aintree Hospitals NHS Trust Liverpool, United Kingdom
NCT05557110
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology Suzhou, Jiangsu, China
NCT02616640
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Local Institution - 102 Baltimore, Maryland, United States
- Local Institution - 114 Boston, Massachusetts, United States
- Local Institution - 108 Boston, Massachusetts, United States
- Local Institution - 115 Boston, Massachusetts, United States
Completed
Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT01243190
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT04998331
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +9 more
- Locations
-
- Hospital General Vega Baja San Bartolomé, Alicante, Spain
- Hospital Universitario de Alava Vitoria-Gasteiz, Araba, Spain
- Ico Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
- Hospital Universitario Galdakao Galdakao, Bizkaia, Spain
Completed
A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma
NCT02529852
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Completed
WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
NCT01827137
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +27 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
NCT05199337
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- University of Southern California Los Angeles, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Tulane University New Orleans, Louisiana, United States
- Washington University St Louis, Missouri, United States